OncoMed Pharmaceuticals, Inc. (OMED) was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend …
NRG Yield (NYLD): Deutsche Bank has a Hold on the stock. OncoMed Pharmaceuticals (OMED): OMED is assigned an Overweight at Piper Jaffray. PMFG Inc (PMFG): Needham has a Hold on the diversified machinery name, as solid …
Get your Free Trial here. OncoMed Pharmaceuticals Inc. (Nasdaq: OMED) presented initial first-in-human data from its …
OncoMed Pharmaceuticals (NASDAQ: OMED) surged 80.40% to $25.40 in the pre-market session ... regulator has closed review of Model S incidents. Morgan Stanley named the stock a Top Pick in the auto sector.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMED at https://www.zacks.com/ap/OMED Keywords: OncoMed …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMED at https://www.zacks.com/ap/OMED Keywords: OncoMed …
A year ago, they were trading at $8.71. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OMED at https://www.zacks.com/ap/OMED
Yahoo!3mon